INTRODUCTION
The propensity of certain proteins to form fibrillar insoluble extracellular deposits in tissues leads to amyloidosis, a severe disease which often affects multiple organs (Glenner, 1980; Stone, 1990) . A variety of amyloidogenic precursors of different origins have been identified; a common structural property is their predominant ,-pleated sheet conformation, which is responsible for the general structural organization of amyloid fibrils.
Monoclonal immunoglobulin light chains are responsible for amyloid light chain (AL)-type amyloidosis. In more than 80 % of cases of AL primary amyloidosis, a monoclonal light chain can be detected by sensitive methods in the patient's urine and/or serum (Gertz & Kyle, 1989) , and in every case careful study of the bone marrow cells demonstrates a significant monoclonal plasma cell population (Buxbaum, 1986; Preud'homme et al., 1988) . Proof of the relationship between plasma cell-secreted and tissue-deposited monoclonal light chains has long been established (Glenner et al., 1971) . Several observations suggest that structural peculiarities of the precursor light chain may play a critical role in the pathogenesis of AL amyloidosis: the A isotype (especially CA3) is largely over-represented (Walker et al., 1988; Gertz & Kyle, 1990) , as is the rare VA6 variability subgroup (Solomon et al., 1982) , and aberrant immunoglobulin biosynthesis patterns were found in bone marrow cells from patients with primary or myeloma amyloidosis (Buxbaum, 1986; Preud'homme et al., 1988) . Although complete primary structures of several AL-type amyloid fibrils have been published in the last decade (Sletten et al., 1981; Eulitz & Linke, 1985; Toft et al., 1985; Tveteraas et al., 1985; Dwulet et al., 1985 Dwulet et al., , 1986 Holm et al., 1986; Benson et al., 1989; Liepnieks et al., 1990) , no specific common sequence could be identified. Unusual structural features of light chains include N-glycosylation (Toft et al., 1985; Tveteraas et al., 1985; Dwulet et al., 1986; Holm et al., 1986) , the presence of numerous hydrophobic residues (Dwulet et al., 1986) and insertion of acidic amino acids (Sletten et al., 1981) . However, these findings do not provide a general explanation for the mechanisms of AL amyloid fibril formation.
Since most amyloid fibrils mainly contain light-chain fragments, often with a length heterogeneity, relevant information might be better obtained from a knowledge ofcomplete structures of amyloidogenic precursor proteins. Only a small number of circulating light-chain amyloid precursors have been studied so far at the molecular level; the three completely determined sequences belonged to the VAl subgroup (Takahashi et al., 1980; Tonoike et al., 1985; Eulitz et al., 1987 stained by anti-a and anti-A fluorescent antibodies; a monoclonal IgA(A) was found in the serum and a A-type Bence-Jones protein in the urine. In all three patients pathological, immunofluorescent and ultrastructural studies of kidney biopsy specimens showed typical fibrillar deposits stained by Congo Red, thioflavine T and anti-K (Arn) or anti-A (Air and Aub) antibodies. In patient Aub, glomerular deposits predominantly involved the epithelial aspect of the capillary walls.
RNA preparations
Cells from the patients' bone marrow were washed with 0.01 M-phosphate-buffered saline, pH 7.4 (PBS; 0.15 M-NaCl) and lysed in 4 M-guanidine isothiocyanate. After a 30 s homogenization with a blender, total RNA was separated by ultracentrifugation for 18 h at 170000 g on 5.7 M-caesium chloride. Northern blot analyses were performed by electrophoresis on 1 % agarose/20 mM-Mops/5 mM-sodium acetate/ 1 mM-EDTA/0.7 M-formaldehyde gels, transfer on to Nylon sheets and hybridization with appropriate DNA probes (Davies et al., 1986) : The K probe was a 2.5 kb EcoRI genomic fragment including the entire constant-region exon; the A probe was a 3.5 kb EcoRI/HindIII fragment containing the CA2 exon (Cogne et al., 1991 Kabat et al. (1987) . The sequence of the constant segment corresponded to a normal Km(3) allele (not shown). Codons corresponding to 5' ends of segments V,Kl, JK5 and CK are indicated.
C, probe was a 1.2 kb PstI genomic fragment containing the 3' end of CH1, the CH2 and 5' part of CH3 exons (Cogne & Preud'homme, 1990) .
Poly(A) mRNA was isolated from total RNA preparations by affinity chromatography on oligo(dT)-cellulose (Pharmacia, Uppsala, Sweden) according to the manufacturer's instructions. cDNA cloning and sequencing cDNA libraries were constructed using standard procedures (Davis et al., 1986 
RESULTS
Analyses of total RNA extracted from the patients' bone marrow samples by Northern blotting with light-chain constantregion probes showed essentially normal-sized transcripts of the respective light chain type (Fig. 1) (Fig. 2) . Comparisons of the deduced peptide sequence with complete VK1 sequences (Kabat et al., 1987) showed ten previously unreported amino acid residues: two in framework region (FR)1 (Gly-18, Leu-2 1), three in FR2 , one in complementaritydetermining region (CDR)2 (Tyr-53), two in FR3 (Leu-60, Asn-70) and two in CDR3 (Ser-92, Phe-96); the sequence AsnTyr-Ser determined a potential N-glycosylation site at position + 70. Among these residues, only Leu-21 was located in a f-sheet (/3-sheet 4-2, Edmundson et al., 1975) . The sequence from patient Air included a VA1 segment rearranged with JA2 and a normal CA2 exon (Fig. 3) . Three aminoacids, Val-52 (CDR2), and Glu-97 (CDR3), had never been found at the corresponding locations in previously described VA1 sequences; all were located in loops between /3-sheets.
The sequence from patient Aub was made up of a VA3, a JA2 and a CA2 segment (Fig. 4) . It included five amino acid residues Vol. 285 which had not been reported at these positions: Ser-30 and Asp-31 in CDR1, His-36 in FR2, Ser-77 in FR3 and Glu-92 in CDR3;
His-36 and Ser-77 were located in ,-sheets 3-1 and 4-3 respectively.
DISCUSSION
AL-type amyloidosis is a structurally heterogeneous entity. Indeed, a feature of each case is visceral deposits of a homogeneous monoclonal light chain and/or its fragments with a unique variable region. This makes the study of structurepathogenicity relationships complex, since large series of experiments are required to be able to draw conclusions. The present results show that cDNA sequencing of the precursor light chain at the secreting clone level is a possible approach, having the following advantages over protein studies: (1) circulating light chains are not always detectable in biological fluids; (2) obtaining fresh tissues containing amyloid proteins is restricted by a number of practical factors; (3) purification of amyloid substances in sufficient amount without proteolysis is tedious and sometimes difficult.
Several structural features of the amyloidogenic light chains reported here are worth noting. Previously unreported or infrequent amino acid residues were found at certain locations. As already suggested by others (Dwulet et al., 1985) , it is probable that these residues present in the framework regions, especially in portions corresponding to f-sheets, are more likely to influence the conformation of the domain than amino acids located in the CDRs.
Amyloidogenic light chain from patient Arn was related to the VKl subgroup, which is the most frequent subgroup among monoclonal K-chains and is slightly over-represented in amyloidosis . Only Leu-21 appeared to be an unusual residue inside a /3-sheet (most sequenced VK1
regions bear an isoleucine at this position) and it is unlikely that it could markedly modify the folding of the light chain. None of the other rare amino acid residues of the sequence from patient Am was found in the two known VK1 amyloid proteins (Dwulet et al., 1986; Liepnieks et al., 1990) . The potential glycosylation site at position + 70 has not previously been described in VK1 light chain. In a patient with light chain deposition disease and a deposited K-light chain of the VK4 subgroup, we have demonstrated that Asn-70 was actually glycosylated (Cogne et al., 1991) ; N-glycosylation could play some role in tissue deposition in both light chain deposition disease and amyloidosis. Indeed, an important proportion of sequenced amyloid light chains, including one of the VKl subgroup (Dwulet et al., 1986), proved to be N-glycosylated (Toft et al., 1985; Tveteraas et al., 1985; Holm et al., 1986; Dwulet et al., 1986) .
The sequence from patient Air belonged to the VA1 subgroup.
Three VA. subgroup amyloidogenic Bence-Jones proteins [NIG51 (Takahashi et al., 1980) , NIG77 (Tonoike et al., 1985) and ZIM (Eulitz et al., 1987) ] and one amyloid substance [EPS, (Toft et al., 1985) ] have already been sequenced. Several rare amino acids (Ala-13, Gly-74 and Gly-89 in fl-sheets 4-1, 4-3 and 3-2 respectively and Thr-80 and Gly-81 in peptide loops) were also present in the amyloid protein EPS. Such similarity between the variable regions of the light chain of patient Air and the protein EPS, especially in the f-sheets, might possibly lead to delineation of an 'amyloidogenic family' inside the VA1 subgroup. However, strong similarities were also found to proteins NIG64 (Tonoike et al., 1985) , New (Langer et al., 1968) and BL2'CL (Tsujimoto & Croce, 1984) , which are not known to be associated with amyloidosis. Finally, it is noticeable that the presence of alanine at position +42 has been reported in the amyloidogenic BenceJones protein NIG51 only (instead of a threonine in 12 out of 13 other VA1 light chains and lysine in the other one) (Takahashi et al., 1980) . The sequence from patient Aub belonged to the VA3 subgroup. Only one such AL-type amyloid variable region had been completely analysed so far (protein Mol; Holm et al., 1986) . None of the infrequent amino acids found in the light chain of patient Aub was present in protein Mol. A striking difference was the absence of an N-glycosylation site in the light chain of patient Aub, whereas protein Mol was glycosylated on Asn-90. The sequence from patient Aub demonstrated a high density of acidic residues in the CDRs. Insertion of two aspartic acid residues between positions 66 and 67 was noted in the VA6 amyloid protein AR (Sletten et al., 1981) , and a possible role for interactions between charged amino acids in amyloid fibril formation has been suggested . This is in accordance with the finding of a low mean isoelectric point for urinary Bence-Jones proteins in amyloidosis (Bellotti et al., 1990) . Patient Aub presented with an unusual type of AL-amyloidosis with predominant perimembranous deposits, as already described in a few cases for which molecular studies had not been carried out (Shiiki et al., 1989) . The study of further patients might allow us to delineate special structural features of perimembranous-type amyloidosis.
In conclusion, our results confirm that the structural abnormalities of immunoglobulin light chains that could play a role in amyloidosis are multiple. cDNA sequencing seems to be a powerful strategy for accumulating molecular data and defining more precisely the complex relationship between light-chain structure and pathogenicity.
